Carmody Leigh C, Gargano Michael A, Toro Sabrina, Vasilevsky Nicole A, Adam Margaret P, Blau Hannah, Chan Lauren E, Gomez-Andres David, Horvath Rita, Kraus Megan L, Ladewig Markus S, Lewis-Smith David, Lochmüller Hanns, Matentzoglu Nicolas A, Munoz-Torres Monica C, Schuetz Catharina, Seitz Berthold, Similuk Morgan N, Sparks Teresa N, Strauss Timmy, Swietlik Emilia M, Thompson Rachel, Zhang Xingmin Aaron, Mungall Christopher J, Haendel Melissa A, Robinson Peter N
The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Med. 2023 Dec 8;4(12):913-927.e3. doi: 10.1016/j.medj.2023.10.003. Epub 2023 Nov 13.
Navigating the clinical literature to determine the optimal clinical management for rare diseases presents significant challenges. We introduce the Medical Action Ontology (MAxO), an ontology specifically designed to organize medical procedures, therapies, and interventions.
MAxO incorporates logical structures that link MAxO terms to numerous other ontologies within the OBO Foundry. Term development involves a blend of manual and semi-automated processes. Additionally, we have generated annotations detailing diagnostic modalities for specific phenotypic abnormalities defined by the Human Phenotype Ontology (HPO). We introduce a web application, POET, that facilitates MAxO annotations for specific medical actions for diseases using the Mondo Disease Ontology.
MAxO encompasses 1,757 terms spanning a wide range of biomedical domains, from human anatomy and investigations to the chemical and protein entities involved in biological processes. These terms annotate phenotypic features associated with specific disease (using HPO and Mondo). Presently, there are over 16,000 MAxO diagnostic annotations that target HPO terms. Through POET, we have created 413 MAxO annotations specifying treatments for 189 rare diseases.
MAxO offers a computational representation of treatments and other actions taken for the clinical management of patients. Its development is closely coupled to Mondo and HPO, broadening the scope of our computational modeling of diseases and phenotypic features. We invite the community to contribute disease annotations using POET (https://poet.jax.org/). MAxO is available under the open-source CC-BY 4.0 license (https://github.com/monarch-initiative/MAxO).
NHGRI 1U24HG011449-01A1 and NHGRI 5RM1HG010860-04.
在临床文献中寻找罕见病的最佳临床管理方法面临重大挑战。我们引入了医学行动本体(MAxO),这是一种专门设计用于组织医疗程序、疗法和干预措施的本体。
MAxO包含将MAxO术语与OBO铸造厂内众多其他本体相链接的逻辑结构。术语开发涉及手动和半自动过程的结合。此外,我们还生成了详细注释,说明了由人类表型本体(HPO)定义的特定表型异常的诊断方式。我们推出了一个网络应用程序POET,它使用Mondo疾病本体为疾病的特定医疗行动提供MAxO注释。
MAxO包含1757个术语,涵盖广泛的生物医学领域,从人体解剖学和检查到生物过程中涉及的化学和蛋白质实体。这些术语注释了与特定疾病相关的表型特征(使用HPO和Mondo)。目前,有超过16000条针对HPO术语的MAxO诊断注释。通过POET,我们创建了413条MAxO注释,指定了189种罕见病的治疗方法。
MAxO提供了对患者临床管理中所采取的治疗及其他行动的计算表示。它的开发与Mondo和HPO紧密结合,拓宽了我们对疾病和表型特征的计算建模范围。我们邀请社区使用POET(https://poet.jax.org/)贡献疾病注释。MAxO根据开源的CC-BY 4.0许可(https://github.com/monarch-initiative/MAxO)提供。
美国国立人类基因组研究所1U24HG011449-01A1和美国国立人类基因组研究所5RM1HG010860-04。